Qui­et neu­rode­gen­er­a­tive dis­ease start­up se­cures $100M from un­named in­vestors

A nine-fig­ure raise is a lot of mon­ey for pri­vate biotechs, and some­thing that many are ea­ger to pub­li­cize. But one start­up is keep­ing its mouth al­most com­plete­ly shut about a new fund­ing round, in­stead draw­ing in an air of mys­tery.

Fos­ter City, CA-based True­Bind­ing, fo­cus­ing on dis­eases such as Alzheimer’s, stroke and can­cer, qui­et­ly dis­closed that it had raised $100 mil­lion late last week, is­su­ing on­ly the fol­low­ing state­ment:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.